Որոնման արդյունքները - Lasocki, Arian
- Ցուցադրվում են 1 - 10 արդյունքները 10
-
1
-
2
-
3
-
4
Improving the diagnosis of radiation necrosis after stereotactic radiosurgery to intracranial metastases with conventional MRI features: a case series Lasocki, Arian, Sia, Joseph, Stuckey, Stephen L.
Հրապարակվել է 2022Տեքստ -
5
High-resolution MRI demonstrates that more than 90% of small intracranial melanoma metastases develop in close relationship to the leptomeninges Lasocki, Arian, Khoo, Chloe, Lau, Peter K H, Kok, David L, Mcarthur, Grant A
Հրապարակվել է 2020Տեքստ -
6
Bevacizumab as a steroid‐sparing agent during immunotherapy for melanoma brain metastases: A case series Banks, Patricia D., Lasocki, Arian, Lau, Peter K. H., Sandhu, Shahneen, McArthur, Grant, Shackleton, Mark
Հրապարակվել է 2019Տեքստ -
7
Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking Gedye, Craig, Sachchithananthan, Mythily, Leonard, Robyn, Jeffree, Rosalind L, Buckland, Michael E, Ziegler, David S, Graeber, Manuel B, Day, Bryan W, McDonald, Kerrie L, Lasocki, Arian, Nowak, Anna K
Հրապարակվել է 2020Տեքստ -
8
OR32-06 Opportunistic Assessment of Pituitary Gland with Routine MRI and PET/CT Can Guide in Earlier and Increased Identification of Hypophysitis in Patients Treated with Combinati... Galligan, Anna, Iravani, Amir, Lasocki, Arian, Wallace, Roslyn, Weppler, Alison, Au-Yeung, George, Sachithanandan, Nirupa, Chiang, Cherie Ying, Wentworth, John, Colman, Peter Grahame, Kay, Thomas William, Krishnamurthy, Balasubramanian, Sandhu, Shahneen
Հրապարակվել է 2020Տեքստ -
9
SUN-127 Diagnostic Challenges Associated with the Rising Incidence of Endocrine Toxicity in the Era of Combination Immunotherapy Galligan, Anna, Iravani, Amir, Lasocki, Arian, Wallace, Roslyn, Weppler, Alison, Au-Yeung, George, Sachithanandan, Nirupa, Chiang, Cherie Ying, Wentworth, John, Colman, Peter Grahame, Kay, Thomas William, Krishnamurthy, Balasubramanian, Sandhu, Shahneen
Հրապարակվել է 2020Տեքստ -
10
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES) Lau, Peter Kar Han, Feran, Breon, Smith, Lorey, Lasocki, Arian, Molania, Ramyar, Smith, Kortnye, Weppler, Alison, Angel, Christopher, Kee, Damien, Bhave, Prachi, Lee, Belinda, Young, Richard J, Iravani, Amir, Yeang, Hanxian Aw, Vergara, Ismael A, Kok, David, Drummond, Kate, Neeson, Paul Joseph, Sheppard, Karen E, Papenfuss, Tony, Solomon, Benjamin J, Sandhu, Shahneen, McArthur, Grant A
Հրապարակվել է 2021Տեքստ